Evidence map›Paper›PMID 40837543›Full record

ArticleJHLT open2025

Alterations in implantable cardioverter defibrillator lead parameters following left ventricular assist device implantation.

David Gittess, David J King, Steven Brady, Ang Li, Yi Guo, Sara Geiger, Mustafa M Ahmed, Alex M Parker, Ramil Goel

Abstract read
In one paragraph

Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David GittessDivision of Internal Medicine, University of Florida, Gainesville, FL.
David J KingDivision of Internal Medicine, University of Florida, Gainesville, FL.
Steven BradyDivision of Internal Medicine, University of Florida, Gainesville, FL.
Ang LiHealth Outcomes & Biomedical Informatics, University of Florida, Gainesville, FL.
Yi GuoHealth Outcomes & Biomedical Informatics, University of Florida, Gainesville, FL.
Sara GeigerDivision of Cardiovascular Medicine, University of Florida, Gainesville, FL.
Mustafa M AhmedDivision of Cardiovascular Medicine, University of Florida, Gainesville, FL.
Alex M ParkerDivision of Cardiovascular Medicine, University of Florida, Gainesville, FL.
Ramil GoelDivision of Cardiovascular Medicine, University of Florida, Gainesville, FL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Left ventricular assist devices (LVADs) are increasingly used in the management of advanced heart failure. The majority of these patients have pre-existing implantable cardioverter defibrillators (ICDs). The proximity between the LVAD inflow cannula and right ventricular (RV) defibrillation lead raises the potential for disruption of ICD function. Methods: This is a retrospective analysis of 95 patients with ICDs at a single tertiary care center who underwent LVAD implantation and who met inclusion criteria. The primary outcome was changes in the pre-operative and post-operative transvenous ICD RV lead parameters. These changes were stratified by the age of the RV lead and analyzed via a paired t-test. The secondary outcome was disruption to the ICD requiring an intervention. Results: LVAD implantation was associated with significant decreases in sensed amplitude (p < 0.01) and high voltage impedance (p < 0.01) and an increase in capture threshold (p = 0.017). When stratified by age of the RV lead, patients with leads older than two years had similar trends in all parameters. However, RV leads that were two years old or younger only showed a significant change in high voltage impedance (p < 0.01). Mechanical disruption of the ICD related to the surgery was infrequent but significant. Conclusion: Because LVAD implantation is capable of impacting ICD function and causing mechanical disruption, close monitoring should be paid to the ICD in the peri-operative period including obtaining a full interrogation.

Indexed as

Advanced heart failureElectrophysiologyImplantable cardioverter defibrillator (ICD)Left ventricular assist device (LVAD)Right ventricular lead disfunction

Identifiers

PMID40837543
PMCPMC12362136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.